Palantir Technologies Inc.

The filings show a sharp turn in reported results. Net income was $1.63 billion in 2025 against $462.19 million in 2024, and operating cash flow was 1.31 times net income. Readers should note that the cash flow statement adds back large noncash items, including $487,628 thousand of stock-based compensation in the first nine months of 2025, so cash generation and reported profit both depend on how that expense is treated. The Beneish M-Score is -1.879, below the -1.78 threshold, and the label places it outside the elevated manipulation-risk zone. In plain English, this screen estimates the likelihood of earnings manipulation from financial ratios, and a score outside the elevated zone means it raised no flag, not that the numbers are verified. The Altman Z-Score is 10.55, in the safe zone, which by that model indicates low near-term balance sheet distress; it does not measure earnings quality or contract durability. The Piotroski F-Score and Fog Index are not in the data provided for this filing, so they are not assessed here. The balance sheet is substantial, with total assets of $8.9 billion against liabilities of $1.41 billion at year-end 2025. Equity was negative $1.98 billion in 2019 and $7.39 billion at 2025, a change that reflects years of losses followed by profit. The filing also cites regulatory exposure, including the FASA and the EU AI Act, and 4,429 full-time employees as of December 31, 2025. Readers may want to look at the reconciliation between operating income of $1.41 billion and net income of $1.63 billion in the full income statement and notes, since the excerpts provided do not explain that gap. They may also want to review the Note 7 commitments and contingencies disclosure and how remaining deal value converts to revenue over time.

Catalyst.According to the 2025 10-K MD&A, growth is tied to contract volume. Total remaining deal value was $11.2 billion at December 31, 2025, including $6.8 billion from commercial customers and $4.4 billion from government customers. Revenue reached $4.48 billion in 2025, up 56.2% from $2.87 billion in 2024. Operating income rose to $1.41 billion from $310.4 million, and operating cash flow reached $2.13 billion versus $1.15 billion. The filing also describes continued spending on pilot deployments and bootcamps, which it says may produce no or minimal future revenue.

Hidden risk.The most material tension is the gap between contracted value and recognized revenue. The MD&A states the company has not historically realized all revenue from full deal value, and many contracts allow termination for convenience. U.S. federal agencies cannot exercise contract options more than one year in advance, and continuing resolutions or funding lapses can delay revenue. In the 10-Q, accounts receivable rose to $1,005,910 thousand at September 30, 2025 from $575,048 thousand at December 31, 2024, an increase of about 75 percent, while the filing notes that billing and payment timing varies by contract.